Although the MEN1 genotype–phenotype correlation is not clear, it is recommended that MEN1 mutation carriers undergo periodic imaging and endocrinological testing to facilitate early cancer detection, especially for thymic carcinoids [35]. The gene discussed is MEN1; the disease is cancer.